Library / regulatory-reference
Argentina: National Administration of Drugs, Foods and Medical Devices (ANMAT)
Audience: administrators-policy, researchers-scientists ยท Review state: published
The national authority
The National Administration of Drugs, Foods and Medical Technology, known by its Spanish initials ANMAT, is Argentina's national regulator for medicines, food, medical devices, cosmetics and related products, operating under the Ministry of Health.
Argentina combines a large domestic pharmaceutical industry with significant exports across Latin America, so the administration's registration and inspection decisions reach well beyond the national market.
How products enter the market
Medicines require registration after evaluation of quality, safety and efficacy, and manufacturers and importers must be licensed, with good-manufacturing-practice inspection of domestic and foreign sites.
The administration supervises the market after approval, operates the national pharmacovigilance system, and controls advertising of medicines to the public.
Regional and international role
The administration is a reference authority within Latin America: it participates in regional regulatory harmonization and its certifications support Argentine exports across the region.
Its framework is often studied as one of the more institutionalized regulatory systems in South America, alongside Brazil's.
Using this profile
The administration publishes registers, dispositions and guidance in Spanish through its official portal, which is the primary source for current rules and listed in this profile's internal reference record.
For cross-country comparison: ANMAT illustrates the established mid-sized reference regulator: broad product scope, export-oriented certification, and regional influence through harmonization work.
Limitations
Educational profile of a national regulatory system, current as of drafting. It simplifies routes and classes and is not legal, regulatory, or clinical advice. Filing and compliance decisions must be confirmed against the authority's current published rules and, where needed, professional regulatory counsel.